REMENS is indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. It is also indicated for use in secondary amenorrhea, as menopausal hormone therapy as an adjunct, prevention of recurrent miscarriage or treatment of threatened abortion.

REMENS is contraindicated in known hypersensitivity to its ingredients, known / suspected pregnancy, thrombophlebitis, thromboembolic disorders, cerebral apoplexy, severe liver disease or dysfunction, known / suspected malignancy of breast or genital organs, undiagnosed vaginal bleeding, missed abortion and as a diagnostic test for pregnancy.

REMENS must be advocated with due precaution in epilepsy, migraine, asthma, cardiac or renal dysfunction, and along with estrogens especially in diabetics.

Before instituting therapy with REMENS, physical examination including especially of breast and genital organs, as well as Papanicolaou smear are advisable. In case of any vaginal bleeding whilst on progesterone (REMENS) adequate diagnostic measures are indicated. REMENS must be promptly discontinued if any manifestations of thrombotic disorders occur. Sudden partial or complete vision loss, onset of proptosis, diplopia, or migraine necessitates withdrawal of REMENS if examination reveals papilledema or retinal vascular lesions.

The most common side effects with progesterone (REMENS) include dizziness, breast pain, headache, abdominal pain, fatigue, viral infection, abdominal distention, musculoskeletal pain, emotional lability, irritability, and upper respiratory tract infections. However, these adverse reactions are lesser with REMENS as it provides natural progesterone (REMENS) as compared to other already available traditional estrogen brands.

Other uncommon reactions include dry mouth, accidental injury, chest pain, fever, anorexia / increased appetite, increased sweating, asthenia, tooth disorder, hypertension, confusion, somnolence, speech disorder, gastrointestinal disturbances, ear ache, palpitations, edema, musculoskeletal complaints, psychiatric manifestations, female genital system abnormalities, respiratory inflammations, acne verruca, wound debridement, urinary tract infection, abnormalvision and lymphadenopathy.

REMENS Soft Gelatin Capsule

PREVENTION OF ENDOMETRIAL HYPERPLASIA: 2 REMENS 100 / 1 REMENS 200 Soft Gelatin Capsule/s as single daily evening dose for 12 days sequentially per 28 day cycle in postmenopausal women who are receiving daily conjugated estrogen tablets.

PREVENTION OF ENDOMETRIAL HYPERPLASIA: 2 REMENS 100 / 1 REMENS 200 Soft Gelatin Capsule/s as single daily evening dose for 12 days sequentially per 28 day cycle in postmenopausal women who are receiving daily conjugated estrogen tablets.

SECONDARY AMENORRHEA: 2 REMENS 200 Soft gelatin Capsules as a single daily evening dose for 10 days.